サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427877

リガーゼ酵素の世界市場レポート 2024

Ligases Enzyme Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
リガーゼ酵素の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

リガーゼ酵素の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.2%の年間複合成長率（CAGR）で49億2,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、個別化医療の応用拡大、合成生物学の重視の高まり、医薬品開発におけるリガーゼ酵素の使用の増加、分子診断の需要の高まり、および次の分野におけるリガーゼの統合によるものと考えられます。世代の順序付け。予測期間の主な動向には、特定の用途に合わせた人工リガーゼの開発、CRISPRベースの技術へのリガーゼ酵素の組み込み、調査と診断の両方のためのリガーゼベースのアッセイのカスタマイズ、リガーゼベースの等温増幅法の出現が含まれます。、診断アッセイにおけるリガーゼ連鎖反応（LCR）の採用。

リガーゼ酵素市場の予想される成長は、がんや遺伝性疾患の有病率の増加によるものです。制御されない細胞増殖を特徴とするがんや、遺伝物質、特にDNAの異常や突然変異に起因する遺伝性疾患が増加しています。 DNAの複製、修復、組換えに重要なリガーゼ酵素は、これらの症状において極めて重要な役割を果たします。がんでは、リガーゼが損傷したDNAを修復し、制御不能な細胞増殖に寄与しますが、遺伝性疾患では、リガーゼを利用して影響を受けた細胞を標的にして排除することができます。特に、2020年に疾病管理予防センターは、米国で1,603,844人の新たながん症例と602,347人の関連死亡を報告しました。さらに、Gene People UKは、英国の子どもの25人に1人が遺伝的疾患に罹患しており、240万人以上がそのような疾患を抱えて暮らしていることを明らかにしました。

研究開発（R&D）活動の急増により、リガーゼ酵素市場の成長が促進されると予想されます。 DNAリガーゼとしても知られるリガーゼ酵素は、DNA分子を結合する際に不可欠なツールであり、さまざまな分野にわたるさまざまな研究開発の取り組みの重要な側面です。たとえば、国立科学工学統計センターは、2020年に米国の研究開発に総額7,170億米ドルが費やされ、2021年には7,919億米ドルと推定されていると報告しました。この研究開発投資の増加は、科学の進歩におけるリガーゼ酵素の重要性を強調しています。と技術革新により、リガーゼ酵素市場の成長が促進されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のリガーゼ酵素市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 大腸菌DNAリガーゼ
  • T4 DNAリガーゼ
  • 哺乳類のリガーゼ
  • 熱安定性リガーゼ
  • 世界のリガーゼ酵素市場、由来別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 微生物
  • 動物
  • 植物
  • 世界のリガーゼ酵素市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • リガーゼ連鎖反応（LCR）
  • リガーゼ検出反応（LDR）
  • 次世代シーケンス（NGS）
  • リピート展開検出（RED）
  • ローリングサークル増幅（RCA）
  • 近接ライゲーションアッセイ（PLA）
  • 分子クローニング
  • ライゲーション媒介PCR
  • 突然変異の検出
  • 世界のリガーゼ酵素市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 研究機関および機関
  • 製薬会社およびバイオ医薬品会社
  • 診ラボ

第7章 地域および国の分析

  • 世界のリガーゼ酵素市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のリガーゼ酵素市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • リガーゼ酵素市場の競合情勢
  • リガーゼ酵素市場の企業プロファイル
    • BASF SE
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Becton Dickinson And Company（BD）

第31章 その他の大手および革新的な企業

  • Agilent Technologies Inc.
  • Illumina Inc.
  • QIAGEN NV
  • Novo Holdings AS
  • GenScript
  • VWR International
  • R And D Systems Inc.
  • Promega Corporation
  • Oxford Nanopore Technologies Limited
  • Takara Bio Inc.
  • New England Biolabs Inc.
  • BioVision Inc.
  • Enzo Life Sciences
  • Zymo Research
  • LGC Biosearch Technologies

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13721

Ligase enzymes, a class of proteins essential for facilitating the union of two DNA strands, play a pivotal role in biotechnology and pharmaceuticals. Their significance extends to various cellular processes, notably DNA replication and protein synthesis.

Key types of ligase enzyme products include E. coli DNA ligase, T4 DNA ligase, mammalian ligases, and thermostable ligases. E. coli DNA ligase specifically refers to an enzyme sourced from Escherichia coli (E. coli) bacteria. These ligases are derived from diverse organisms, including microorganisms, animals, and plants. They are integral to a multitude of techniques, encompassing ligase chain reaction (LCR), ligase detection reaction (LDR), next-generation sequencing (NGS), repeat expansion detection (RED), rolling circle amplification (RCA), proximity ligation assay (PLA), molecular cloning, ligation-mediated PCR, and mutation detection. These versatile applications cater to a broad spectrum of end-users, including research laboratories and institutions, pharmaceutical and biopharmaceutical companies, as well as diagnostic laboratories.

The ligases enzyme market research report is one of a series of new reports from The Business Research Company that provides ligases enzyme market statistics, including ligases enzyme industry global market size, regional shares, competitors with a ligases enzyme market share, detailed ligases enzyme market segments, market trends and opportunities, and any further data you may need to thrive in the ligases enzyme industry. This ligases enzyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. 

The ligases enzyme market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.21 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth observed in the historic period of ligase enzymes can be attributed to several factors. Initially, the discovery and development of ligase enzymes played a crucial role in their increased utilization. Additionally, the growth of the biotechnology industry provided a conducive environment for the advancement and application of ligase enzymes. A heightened understanding of DNA repair mechanisms further contributed to their significance in various cellular processes. The expansion of genetic engineering applications, facilitated by ligase enzymes, also played a role in their increased demand. Lastly, the rise in demand for molecular diagnostics, where ligase enzymes find application, further fueled their growth during this historic period.

The ligases enzyme market size is expected to see rapid growth in the next few years. It will grow to $4.92 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth during the forecast period can be ascribed to the expanding applications of personalized medicine, a heightened emphasis on synthetic biology, the increasing use of ligase enzymes in drug development, a rising demand for molecular diagnostics, and the integration of ligases in next-generation sequencing. Key trends in the forecast period encompass the development of engineered ligases tailored for specific applications, the incorporation of ligase enzymes in CRISPR-based technologies, the customization of ligase-based assays for both research and diagnostics, the emergence of ligase-based isothermal amplification methods, and the adoption of ligase chain reaction (LCR) in diagnostic assays.

The anticipated growth of the ligase enzyme market is attributed to the increasing prevalence of cancer and genetic disorders. Cancer, characterized by uncontrolled cell growth, and genetic disorders, resulting from abnormalities or mutations in genetic material, particularly DNA, are on the rise. Ligase enzymes, crucial for DNA replication, repair, and recombination, play a pivotal role in these conditions. In cancer, ligases repair damaged DNA, contributing to uncontrolled cell growth, while in genetic disorders, ligases can be utilized to target and eliminate affected cells. Notably, in 2020, the Centers for Disease Control and Prevention reported 1,603,844 new cancer cases and 602,347 related deaths in the United States. Additionally, Gene People UK revealed that 1 in 25 children in the UK is affected by a genetic condition, with over 2.4 million individuals living with such disorders.

An upsurge in research and development (R&D) activities is expected to drive the ligase enzyme market's growth. Ligase enzymes, also known as DNA ligases, are essential tools in joining DNA molecules-a critical aspect of various R&D endeavors across diverse fields. For instance, in 2020, the National Center for Science and Engineering Statistics reported a total of $717.0 billion spent on R&D in the United States, with an estimated $791.9 billion for 2021. This increase in R&D investment underscores the significance of ligase enzymes in advancing scientific and technological innovations, thereby fueling the growth of the ligase enzyme market.

Product innovation is emerging as a notable trend in the ligase enzyme market, with major companies actively pursuing the development of novel ligases to solidify their market positions. A prime example is ArcticZymes Technologies ASA, a Norway-based biotechnology firm, which unveiled the ArcticZymes R2D Ligase in December 2021. This patent-pending ligase demonstrates unique specificity, allowing the ligation of DNA to both ends of RNA using a DNA splint. Anticipated to have broad applications in molecular diagnostics, next-generation sequencing, and gene/RNA synthesis for potential therapeutic uses, this enzyme stands out for its high activity and efficiency, making it suitable for diverse applications.

Strategic partnerships are also becoming a focal point for major companies in the ligase enzyme market. Lonza Group, a Switzerland-based company operating in the pharmaceutical, biotechnology, and nutrition sectors, formed a partnership with Singzyme, a Singapore-based company specializing in enzyme development, in September 2021. This collaboration grants Lonza access to Singzyme's enzymatic conjugation platform, enabling site-specific binding of payloads with peptidic linkers to proteins-particularly advantageous for precision medicine applications such as cancer treatment. The ligase-specific tag sequence-based technique ensures versatility in handling various payload types and shorter development timescales.

In May 2022, QIAGEN N.V., a Germany-based provider of molecular testing solutions, acquired a majority stake in BLIRT S.A., a Poland-based biotechnology company known for manufacturing specialty ligase enzymes and reagents. This strategic acquisition is aimed at expanding QIAGEN's sample technology business by leveraging BLIRT's technology and expertise, thereby reinforcing QIAGEN's position in the life science industry. This strategic maneuver underscores the importance of inorganic growth strategies for gaining a competitive edge in the dynamic ligase enzyme market.

Major companies operating in the ligases enzyme market report are BASF SE, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Novo Holdings AS, GenScript, VWR International, R And D Systems Inc., Promega Corporation, Oxford Nanopore Technologies Limited, Takara Bio Inc., New England Biolabs Inc., BioVision Inc., Enzo Life Sciences, Zymo Research, LGC Biosearch Technologies, Genetix Biotech Asia Pvt. Ltd., BLIRT S.A., Jena Bioscience, Bioline, Creative Enzymes, ArcticZymes Technologies ASA

North America was the largest region in the ligases enzyme market in 2023. Asia-Pacific is expected to be the fastest-growing region in the ligases enzyme market report during the forecast period. The regions covered in the ligases enzyme market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ligases enzyme market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ligases enzyme market consists of sales of hi-t4 DNA ligase, splintR ligase, salt-t4 DNA ligase, t7 DNA ligase, quick ligation kits, Taq DNA ligase, and electroLigase. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ligases Enzyme Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ligases enzyme market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ligases enzyme ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ligases enzyme market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: E. coli DNA ligase; T4 DNA Ligase; Mammalian Ligases; Thermostable Ligases
  • 2) By Source: Microorganisms; Animal; Plant
  • 3) By Application: Ligase Chain Reaction (LCR); Ligase Detection Reaction (LDR); Next-Generation Sequencing (NGS); Repeat Expansion Detection (RED); Rolling Circle Amplification (RCA); Proximity Ligation Assay (PLA); Molecular Cloning; Ligation Mediated PCR; Mutation Detection
  • 4) By End-User: Research Laboratories And Institutions; Pharmaceutical And Biopharmaceutical Companies; Diagnostic Laboratories
  • Companies Mentioned: BASF SE; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson And Company (BD)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ligases Enzyme Market Characteristics

3. Ligases Enzyme Market Trends And Strategies

4. Ligases Enzyme Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Ligases Enzyme Market Size and Growth

  • 5.1. Global Ligases Enzyme Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Ligases Enzyme Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Ligases Enzyme Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ligases Enzyme Market Segmentation

  • 6.1. Global Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • E. coli DNA ligase
  • T4 DNA Ligase
  • Mammalian Ligases
  • Thermostable Ligases
  • 6.2. Global Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Microorganisms
  • Animal
  • Plant
  • 6.3. Global Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ligase Chain Reaction (LCR)
  • Ligase Detection Reaction (LDR)
  • Next-Generation Sequencing (NGS)
  • Repeat Expansion Detection (RED)
  • Rolling Circle Amplification (RCA)
  • Proximity Ligation Assay (PLA)
  • Molecular Cloning
  • Ligation Mediated PCR
  • Mutation Detection
  • 6.4. Global Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Laboratories And Institutions
  • Pharmaceutical And Biopharmaceutical Companies
  • Diagnostic Laboratories

7. Ligases Enzyme Market Regional And Country Analysis

  • 7.1. Global Ligases Enzyme Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Ligases Enzyme Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ligases Enzyme Market

  • 8.1. Asia-Pacific Ligases Enzyme Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ligases Enzyme Market

  • 9.1. China Ligases Enzyme Market Overview
  • 9.2. China Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ligases Enzyme Market

  • 10.1. India Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ligases Enzyme Market

  • 11.1. Japan Ligases Enzyme Market Overview
  • 11.2. Japan Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ligases Enzyme Market

  • 12.1. Australia Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ligases Enzyme Market

  • 13.1. Indonesia Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ligases Enzyme Market

  • 14.1. South Korea Ligases Enzyme Market Overview
  • 14.2. South Korea Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ligases Enzyme Market

  • 15.1. Western Europe Ligases Enzyme Market Overview
  • 15.2. Western Europe Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ligases Enzyme Market

  • 16.1. UK Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ligases Enzyme Market

  • 17.1. Germany Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ligases Enzyme Market

  • 18.1. France Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ligases Enzyme Market

  • 19.1. Italy Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ligases Enzyme Market

  • 20.1. Spain Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ligases Enzyme Market

  • 21.1. Eastern Europe Ligases Enzyme Market Overview
  • 21.2. Eastern Europe Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ligases Enzyme Market

  • 22.1. Russia Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ligases Enzyme Market

  • 23.1. North America Ligases Enzyme Market Overview
  • 23.2. North America Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ligases Enzyme Market

  • 24.1. USA Ligases Enzyme Market Overview
  • 24.2. USA Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ligases Enzyme Market

  • 25.1. Canada Ligases Enzyme Market Overview
  • 25.2. Canada Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ligases Enzyme Market

  • 26.1. South America Ligases Enzyme Market Overview
  • 26.2. South America Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ligases Enzyme Market

  • 27.1. Brazil Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ligases Enzyme Market

  • 28.1. Middle East Ligases Enzyme Market Overview
  • 28.2. Middle East Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ligases Enzyme Market

  • 29.1. Africa Ligases Enzyme Market Overview
  • 29.2. Africa Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ligases Enzyme Market Competitive Landscape And Company Profiles

  • 30.1. Ligases Enzyme Market Competitive Landscape
  • 30.2. Ligases Enzyme Market Company Profiles
    • 30.2.1. BASF SE
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton Dickinson And Company (BD)
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Ligases Enzyme Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. QIAGEN N.V.
  • 31.4. Novo Holdings AS
  • 31.5. GenScript
  • 31.6. VWR International
  • 31.7. R And D Systems Inc.
  • 31.8. Promega Corporation
  • 31.9. Oxford Nanopore Technologies Limited
  • 31.10. Takara Bio Inc.
  • 31.11. New England Biolabs Inc.
  • 31.12. BioVision Inc.
  • 31.13. Enzo Life Sciences
  • 31.14. Zymo Research
  • 31.15. LGC Biosearch Technologies

32. Global Ligases Enzyme Market Competitive Benchmarking

33. Global Ligases Enzyme Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ligases Enzyme Market

35. Ligases Enzyme Market Future Outlook and Potential Analysis

  • 35.1 Ligases Enzyme Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Ligases Enzyme Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Ligases Enzyme Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer